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ABSTRACT 
We present the application of two fibre-optic-coupled time-resolved spectrofluorometers and a compact steady-state 
diffuse reflected light/fluorescence spectrometer to in vivo and ex vivo studies of skin cancer and osteoarthritis. In a 
clinical study of skin cancer, 27 lesions on 25 patients were investigated in vivo before surgical excision of the region 
measured. Preliminary analysis reveals a statistically significant decrease in the autofluorescence lifetime of basal cell 
carcinomas compared to neighbouring healthy tissue. A study of autofluorescence signals associated with the onset of 
osteoarthritis indicates autofluorescence lifetime changes associated with collagen degradation.   
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1. INTRODUCTION 
The intrinsic “autofluorescence” from biological tissue is of interest when studying disease due to the wide range of 
naturally occurring fluorophores that, through changes in their fluorescence properties, can report on altered metabolism, 
protein cross links, cell signaling and even disease state 1-7. In particular the fluorescence lifetime of endogenous 
fluorophores, which is relatively insensitive to fluorophore concentration and to signal attenuation by the sample, has 
been shown to effectively differentiate between healthy and diseased tissue, for example in brain tumours, skin cancer 
and atherosclerotic plaques 7-9. Accordingly, there is currently much research underway looking into the design and 
implementation of instruments to measure autofluorescence properties for clinical diagnosis, some examples of which 
are found in references 10-16. Besides the potential to provide increased sensitivity and specificity, such instruments could 
be less invasive and produce faster results than the current gold standard technique of biopsy and histopathology 10. 
Here we describe two time-resolved fluorescence spectrofluorometers and a compact steady-state diffuse 
reflected light/fluorescence spectrometer designed to investigate the clinical diagnostic potential of tissue 
autofluorescence and present data from an in vivo study of skin cancer and an ex vivo study of osteoarthritis. The two 
time-resolved fluorometer systems were developed at Imperial College London and utilise a fibre-optic probe to deliver 
excitation and collect fluorescence for the parallel measurement of the autofluorescence decay profiles in a number of 
spectral channels. The compact steady-state diffuse reflected light/fluorescence spectrometer was developed at Lund 
University and combines measurements of spectrally resolved fluorescence and diffuse reflectance for four excitation 
wavelengths.   
For the in vivo study of skin cancer, which was undertaken with 27 lesions on 25 patients at Lund University 
Hospital, we investigated the diagnostic potential of a dual excitation wavelength hyperspectral fluorescence lifetime 
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fibre probe 17 and the steady-state diffuse reflected light/fluorescence spectrometer. Such a study is desirable because the 
methodology used to diagnose skin cancer currently involves a clinical examination by a dermatologist and subsequent 
histopathology of an excised tissue biopsy. This is both time consuming and invasive and the clinical examination is a 
subjective procedure that can sometimes lead to the unnecessary removal of benign lesions 10, 18. Noting that skin cancer 
is one of the most common forms of malignancy (accounting for nearly half of all cancers in the USA) 19, it seems clear 
that a non-invasive (optical) method of diagnosis that removed the need for a physical biopsy would be a useful 
development.   
For the study of osteoarthritis undertaken at Imperial College London, the second time-resolved 
spectrofluorometer was applied to investigate autofluorescence signals from ex vivo cartilage tissue. These tissue 
samples were obtained as porcine trotters or bovine hooves and first processed to extract the cartilage. The purified 
samples were then treated to simulate the effects of osteoarthritis in terms of collagen degradation. Time-resolved 
autofluorescence emission spectra were then recorded for each sample in order to investigate whether such 
autofluorescence signatures of cartilage could be used to detect the onset of disease 20.  
 
 
 
Figure 1. (Colour online) (a) Experimental layout of the fluorescence lifetime fibre probe spectrofluorometer (spectrometer 
A) and (b) an example of the raw data obtained exciting a solution of NADH with 355 nm radiation. Diagram reproduced, 
with permission, from (De Beule et al., 2007) 17. © 2007, American Institute of Physics. 
 
 
2. INSTRUMENTATION 
2.1 Time-resolved fibre-optic probe spectrofluorometer (A) 
The first of the two time-resolved spectrometers (A) was developed by De Beule et al. 17. This system was configured as 
shown in figure 1(a). Excitation light was provided by two pulsed laser sources – a frequency tripled ultrafast Yb:glass 
fibre laser (UVPower355, Fianium Ltd., UK), which provided 10 ps pulses at 355 nm with a repetition rate of 37.1 MHz 
and up to 200 mW of average power, and a diode laser (LDH-P-C-440B, PicoQuant GmbH, Germany), which emitted 
50-150 ps pulses at 445 nm with an adjustable repetition rate of up to 40 MHz and up to ~3 mW average power. A 
maximum power of 10 µW of UV irradiation and 50 µW of blue irradiation was used for the in vivo experiments. This 
radiation was coupled into the excitation channel of a custom built fibre-optic probe (FiberTech Optica, Canada) that 
comprised seven multimode optical fibres – six for collection of fluorescence and one for delivery of the excitation – 
each with a core diameter of 200 µm. At the distal end of the probe, the fibres are arranged with the central excitation 
fibre surrounded by the six collection fibres (inset at top right of figure 1(a)). This arrangement was designed to optimise 
the illumination and collection efficiency while maintaining a relatively small probe size. At the output to the 
spectrograph, the six collection fibres are positioned in a line (inset at top centre of figure 1(a)) in order to maximise the 
coupling into the input slit of the spectrograph. Spectral bandpass filters were employed to clean up the diode emission 
and to ensure none of the fundamental radiation (at 1.06 μm) from the Yb:glass fibre laser was transmitted to the sample. 
Computer controlled mechanical shutters in the two beam paths were used to switch between the two excitation sources. 
The output from the excitation optical fibre was directed onto the sample over an area of ~0.2 mm2 and the resulting 
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fluorescence was collected by the six multimode collection fibres which surround the central excitation optical fibre in 
the FiberTech probe. The output from these collection optical fibres was then imaged onto the input slit of a grating 
spectrometer (MS125 1/8m, Lot-Oriel, UK) which was attached to a 16 channel multi-anode photomultiplier tube (PMT) 
detector (PML-16-C, Becker-Hickl GmbH, Germany). The PMT was linked to a computer with a SPC-730 time 
correlated single photon counting (TCSPC) card running SPCM software (Becker-Hickl GmbH, Germany) so that 
fluorescence decay profiles could be recorded in 16 spectral channels. Note that a motorised filter wheel was also placed 
in the beam path between the fibre probe output and the spectrograph to ensure that no stray scattered laser light reached 
the 16 channel detector. The whole system was mounted on a 60 x 60 cm2 breadboard to facilitate transportation and 
fully enclosed for safe use in clinical settings.  
 A single dataset acquired using this instrument consists of two temporally interleaved sets of 16 spectrally 
resolved fluorescence decay profiles, one for 355 nm excitation and one for 445 nm excitation. Typically, for each 
sample we make three identical measurements with each laser with exposure times of around 5 s and so the total 
acquisition time is on the order of 30 s. An example of the raw data obtained when exciting a solution of NADH with 
355 nm excitation is shown in figure 1(b). Before analysis the raw data is corrected to account for the instrument 
response function of the spectrograph and the non-uniform channel sensitivity of the 16 channel PMT. This was achieved 
firstly by determining the spectral location of each PMT element using a white light source and a calibrated 
monochromator and, secondly, by correcting for the intensity in each channel by measuring a known standard 17. 
 
 
Figure 2. (Colour online) Experimental setup (a) for the multidimensional spectrofluorometer (spectrometer B) and an 
illustration showing the arrangement of the fibres at the illumination end of the custom fibre probe (b). Blue signifies 
illumination fibres while red fibres are for collection. Adapted from reference 21. © Wiley-VCH Verlag GmbH & Co. 
KGaA. Reproduced with permission. 
 
 
2.2 Multidimensional fluorometer exploiting supercontinuum generation (B) 
The multidimensional fluorometer (B) is also a time-resolved spectrophotometer but incorporates a compact fibre-laser-
pumped supercontinuum source (SPC-400, Fianium, UK) to provide picosecond pulses at 20 MHz repetition rate over a 
wider range (400-800 nm) of excitation wavelengths and can also utilise excitation radiation from an external source if 
necessary. For the experiments presented here, a diode-pumped frequency-tripled Neodymium Vanadate laser (Vanguard 
350-HM355, Spectra-Physics, USA) was used as the external excitation source, which provided 12 ps pulses at 355 nm 
with 80 MHz repetition rate and up to ~400 mW average power.  This fluorometer is able to resolve fluorescence signals 
using TCSPC with respect to both excitation and emission wavelength and also with respect to polarisation. It can be 
configured for internal cuvette measurements, as shown in figure 2(a), or for external measurements via a custom-built 
fibre-optic probe (FiberTech Optica, Canada) that incorporates three excitation fibres and 16 collection fibres, as 
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depicted in figure 2(b). This external fibre-optic probe, which can be mounted vertically in the same location as the 
cuvette and uses the same collection optics, was used for the experiments reported here. The fluorometer can switch 
between two detection arms: one using a spectrograph and a 16 channel TCSPC detector (as described above for 
spectrometer A) and another with a motorised monochromator (CM110, CVI Inc., USA) and a cooled photomultiplier 
(PMC-100, Becker-Hickl GmbH, Germany) for single channel TCSPC detection, permitting large spectral regions to be 
analysed with high resolution 21. 
 
  
2.3 Wide-field steady-state spectrometer (C) 
The third instrument employed for the work described here measures diffuse reflectance spectra and fluorescence spectra 
with three different excitation wavelengths and was developed at the Atomic Physics Division of Lund University in 
Sweden. It was specifically designed to be compact and portable and is controlled using software written in Matlab® 
(MathWorks™) running on a laptop computer. The measurement head, which is represented in figure 3(a), is coupled to 
a small spectrometer (USB4000, cylindrical lens and second order rejection filter installed, Ocean Optics Inc.) that 
provides 3 nm resolution and the whole system fits into a small (20x15x15 cm) portable case. 
 The instrument incorporates seven continuous wave LED sources (Roithner Lasertechnik) comprising a 430 nm 
LED, a white light LED (Blue+Ce:YAG conversion, 450-700 nm) and two near infrared LEDs (750 nm and 850 nm) for 
reflectance measurements and LEDs at 355 nm, 375 nm and 395 nm for fluorescence measurements. The emission from 
the UV LEDs is passed through clean up filters (1mm UG1 or UG11) and each source is directed toward the same 
central measurement site. The angles of incidence and the use of non-contact optics in the system are designed to 
minimise specular reflections. For a typical measurement, the sample is illuminated by each source sequentially and the 
fluorescence or diffuse reflected light passes through a 420 nm long pass emission filter (3 mm GG420) and is collected 
by a 600 µm diameter optical fibre that delivers the light to the spectrometer. The LEDs and filters are contained within a 
copper shell, and the thermal dependence of the emissive yield is compensated for by measuring the voltage-current 
characteristics. Dark spectra are recorded by switching off the sources and these are subtracted from the clinical 
measurements. The reflectance is calibrated with a 50% grey reference (Oriel) and the fluorescence intensity counts are 
white calibrated with a filament source (Oriel). In a typical acquisition, the reflectance and fluorescence spectra are 
recorded at each excitation wavelength in sequence, requiring a total acquisition time of approximately 30 s when 
averaging over 5 measurements. A graph showing exemplar data of human skin is shown in figure 3(b), which indicates 
some key features of the spectra. A more complete description of this system can be found in the paper by Brydegaard et 
al. (2010) 22 where it was used to study fluorescence from bird feathers. 
 
 
 
Figure 3. (Colour online) (a) Cross-section through the measurement head of the multi-channel spectrometer (instrument C) 
and (b) an example dataset from this system – recorded in vivo – showing reflectance and fluorescence spectra from human 
skin. 
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3. EXPERIMENTAL PROCEDURES 
3.1 In vivo clinical study of skin cancer 
The time-resolved fibre probe (A) and the steady-state wide-field (C) spectrometers were applied together in a clinical in 
vivo study of skin cancer undertaken in the Department of Dermatology at Lund University Hospital. In this 
investigation, 27 clinically diagnosed skin cancer lesions on 25 patients were examined before excision with the patients 
being invited to take part in the study after having been clinically assessed by a dermatologist. With the patients’ 
consent, time-resolved measurements of the autofluorescence and steady-state measurements of the autofluorescence and 
diffuse reflectance were made at the site of each lesion, both in the lesion and in neighbouring “normal” tissue to provide 
a comparison of their emission and absorption properties. The steady-state spectrometer (C) was applied once to each 
site while the time-resolved spectrometer (A) was used to make two measurements of normal tissue and one to four 
measurements within each lesion depending on its size. Afterwards, the entire region irradiated with the fibre probe 
system was removed and sent to histopathology. Figure 4 illustrates the measurement procedure. Here the filled circles 
give the positions of the fibre probe measurements on lesion (red), healthy (green) and marginal (orange) tissue. The 
dotted black circles indicate where the fluorescence and diffuse reflectance spectra were recorded using the steady-state 
spectrometer. Finally, the dotted red circles indicate the region of tissue that was surgically excised. For each lesion site, 
the time-resolved fibre probe instrument (A) provided a set of 16 spectrally resolved fluorescence decay profiles for each 
of the two excitation wavelengths while the steady state spectrometer provided a diffuse reflectance spectrum and an 
autofluorescence spectrum for each of its three excitation wavelengths. 
 
 
 
 
Figure 4. (Colour online) Illustration of the procedure for measuring autofluorescence and reflectance of skin cancer lesions 
in vivo. Both diagrams show a lesion (dark central region) surrounded by healthy tissue (lighter region). The small circles 
show the location of the fibre probe measurements (red - lesion, green - healthy, orange - marginal), the dotted black circles 
illustrate where the multi-channel spectrometer was used and the dotted red lines indicate the surgically removed areas. 
 
 
3.2 Point probe multidimensional fluorescence measurements of cartilage degradation simulating the effects of 
osteoarthritis 
The second study presented here used the multidimensional fluorometer (B) discussed in section 2.2 to study 
autofluorescence signals from cartilage with a view to investigating their potential for diagnosing tissue degradation due 
to osteoarthritis. Our methodology was to chemically treat ex vivo cartilage samples to simulate the effects of 
osteoarthritis and to investigate whether the autofluorescence from the tissue could provide information regarding its 
state of degradation – for which the two main causes are the breakdown of collagen (collagenolysis) and the loss of 
aggrecan (aggrecanolysis). As collagen is a predominant fluorophore in cartilage, it can be expected that its degradation 
will affect the autofluorescence signal.  
In this study, sections of cartilage excised from porcine trotter joints were excited using 355 nm radiation from a 
mode-locked frequency-tripled Neodymium Vanadate laser (Vanguard 350-HM355, Spectra-Physics, USA) and time-
resolved fluorescence spectra were recorded. Initially normal cartilage was investigated in order to provide a baseline 
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against which any tissue degradation could be compared. We also compared porcine cartilage to bovine cartilage to 
assess the differences in autofluorescence from different tissue types. To induce collagenolysis, porcine cartilage was 
treated with doses of between 0 and 100 µg/ml of bacterial collagenase, thereby simulating one cause of osteoarthritis.  
Following this treatment, the fluorescence lifetime was measured with an excitation wavelength of 355 nm. Thus, we 
investigated the effects of the collagenase dose on the autofluorescence signature of the cartilage 20. 
 
 
4. RESULTS AND DISCUSSION 
4.1 In vivo clinical study of skin cancer 
 
Steady state spectral measurements 
 
As discussed above, 27 clinically diagnosed cancerous lesions were examined in vivo using instruments A and C, (as 
described in sections 2.1 and 2.3). Figure 5 presents an example of the steady-state spectral data (instrument C) for a 
specific lesion that was subsequently diagnosed as a basal cell carcinoma (BCC). The graphs show a reflectance 
spectrum and three fluorescence spectra (one for each excitation wavelength) for the lesion and for adjacent “normal” 
tissue. The instrument was calibrated as discussed in section 2.3 and so the spectral intensities can be compared across 
different acquisitions. 
 
 
Figure 5. (Colour online) Example spectra from normal (left) and lesional (right) tissue recorded using the steady-state 
spectrometer (C). Data was taken from a single lesion site where the final diagnosis was BCC. Spectral intensities from 
different acquisitions can be compared due to the calibration of the instrument discussed in section 2.3. 
 
 
 Figure 5 shows significant differences between the spectra recorded on the lesion and the adjacent normal 
tissue. We note however, that there was considerable inter-patient variability in the acquired spectra and this is illustrated 
in figure 6, which shows the mean diffuse reflectance for healthy and diseased tissue for all the measured BCC and 
actinic keratosis lesions. In these graphs the solid lines show the mean spectra and the dotted lines indicate the standard 
deviations, with the red (lower) curves corresponding to the lesions and the blue (upper) curves to the normal tissue. For 
both BCC and actinic keratosis lesions, the mean reflectance is lower than for the surrounding healthy tissue. This trend 
was observed for all lesion types but we note the significant spread in the data as indicated by the standard deviations.  
We are currently carrying out a single value decomposition (SVD) analysis of all of the spectra in a method similar to 
that used by Butte et al. 16 and the results of this analysis will be presented elsewhere. We are also investigating 
ratiometric analysis in discrete spectral bands and correlating the results with disease type. 
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Figure 6. (Colour online) Graphs showing the mean reflectance spectra for all BCC (left) and actinic keratosis (right) 
lesions. Solid curves show the mean reflectance values and the dotted lines give confidence intervals of ± 1 standard 
deviation. Blue (upper) lines represent the measurements taken on healthy tissue while the red (lower) curves represent the 
lesional data. 
 
 
Time-resolved autofluorescence measurements 
 
Figure 7 shows the data from the time-resolved spectrofluorometer (instrument A). A comparison of the integrated 
spectra (for 355 nm excitation) was compared to those obtained for the same excitation wavelength using the steady state 
spectrometer and the two instruments were found to be in good agreement. For the time-resolved data, the fluorescence 
lifetimes were determined using phasor analysis 23 such that a phase and a modulation lifetime were obtained for each of 
the 16 spectral channels for each tissue measurement. Figure 7(a) and (b) show the mean emission wavelength for each 
patient for the normal and lesion measurements. Figure 7(c) and (d) show the mean fluorescence phase lifetime for the 
same patients. It can be seen that, for 355 nm excitation, there is no clear trend in the mean autofluorescence phase 
lifetime or mean emission wavelength to distinguish the lesions from normal tissue. For 445 nm excitation, however, 
there is a clear trend with the lesions exhibiting lower autofluorescence lifetimes than the surrounding healthy tissue in 
all cases, i.e. τlesion < τnormal. A statistical analysis of this data is underway and will be presented elsewhere. 
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Figure 7. (Colour online) Mean emission wavelength and phase lifetimes for all BCC measurements with UV (left) and blue 
excitation (right). In (a) and (b), the mean emission wavelength for each patient is given for UV and Blue excitation respectively.  
In (c) and (d) the mean phase lifetime is given for UV and Blue excitation respectively. 
 
 
4.2 Multidimensional fluorescence measurements of ex vivo cartilage 
 
Fluorescence from normal cartilage 
 
As a first step, an investigation was undertaken to study the emission of normal cartilage. It was observed that cartilage 
from different sources (i.e. bovine and porcine cartilage) had significantly different autofluorescence lifetimes (data not 
shown) and that there could be considerable variation from animal to animal. Most of our subsequent studies were 
undertaken with porcine cartilage with excitation at 355 nm, for which no significant variation of autofluorescence 
lifetime with emission wavelength was observed and the peak of the emission spectrum occurred at approximately 
415 nm. The autofluorescence decay profiles were described well by a double exponential decay model while fitting to a 
single exponential model produced a much poorer fit to the data 20. 
 
 
Treatment with bacterial collagenase 
 
A study was undertaken to investigate the effect of degrading cartilage with bacterial collagenase as a convenient model 
to simulate the cartilage degradation during osteoarthritis. Samples were treated with bacterial collagenase and their 
autofluorescence was then studied as a function dose. The first studies showed that there was little discernible difference 
between the emission spectra of a control (untreated) sample and a cartilage sample treated with the collagenase – as 
shown in figure 7(a). In terms of autofluorescence lifetime, however, a clear trend was apparent. Figure 7(b) shows how 
the mean autofluorescence lifetime decreased as a function of concentration of bacterial collagenase. For this data, 
autofluorescence decay profiles at 415 nm were fitted to a double exponential decay model and the mean lifetime was 
calculated from this fit. This decrease in mean autofluorescence lifetime as a function of increasing dose of collagenase 
is attributed to a decrease in the lifetime of the long component of the double exponential fit and to an increase in the 
magnitude of the short component 20. 
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Figure 8. (Colour online) Graphs showing (a) fluorescence spectra from control collagen and collagen treated with 
100 µg/ml bacterial collagenase, and (b) the fluorescence lifetime recorded at 415 nm as a function of dose 20. 
 
 
5. CONCLUSIONS 
In this paper we have presented three instruments for the analysis of spectroscopic properties of biological tissue that we 
have applied to the diagnosis of disease. An ultrafast laser-based time-resolved spectrofluorometer coupled to a fibre 
optic probe (A) and a compact LED-based steady-state tissue spectrometer (C) have been applied in an in vivo clinical 
investigation of skin cancer at Lund University Hospital. This study, which involved the investigation of 27 lesions, 
indicated clear differences between healthy and diseased tissue both in terms of spectral properties and autofluorescence 
lifetime (for excitation at 445 nm), indicating the potential of these instruments for clinical diagnostic purposes. Future 
work will involve increasing the number of lesions investigated such that it is possible to draw statistically significant 
conclusions for several individual sub-classes of skin cancer such as squamous cell carcinomas and malignant 
melanomas. 
 An investigation was also undertaken of the diagnostic potential of autofluorescence for osteoarthritis. In this 
preliminary study time-resolved autofluorescence measurements were made of cartilage extracted from porcine trotters 
using a multidimensional fluorometer (C). When cartilage was treated with bacterial collagenase to simulate the collagen 
degradation associated with osteoarthritis, a significant decrease in autofluorescence lifetime was observed, while there 
was no marked change in the emission spectral profile. Further work will be aimed mainly at more accurately simulating 
the in vivo degradation of collagen and also investigating the potential of autofluorescence to read out the loss of 
aggrecan from cartilage, which is also associated with osteoarthritis. 
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